Publication:
Systemic lupus erythematosus and antiphospholipid syndrome

dc.contributor.authorPlavsic, Aleksandra (24169362300)
dc.contributor.authorMiskovic, Rada (56394650000)
dc.contributor.authorRaskovic, Sanvila (6602461528)
dc.contributor.authorBogic, Mirjana (18333561400)
dc.contributor.authorNikolic, Branka Bonaci (36905814200)
dc.date.accessioned2025-06-12T20:18:27Z
dc.date.available2025-06-12T20:18:27Z
dc.date.issued2014
dc.description.abstractAntiphospholipid syndrome is an autoimmune disorder defined as association of vascular thrombosis and/or pregnancy complications with presence of antiphospholipid antibodies (lupus anticoagulant, anticardiolipin and anti-β2 glycoprotein I). It is the most common cause of acquired thrombophilia, and can occur as an independent entity or in relation with other diseases, especially systemic lupus erythematosus. Presence of antiphospholipid syndrome in systemic lupus erythematosus is additional vaso occlusive factor in already present inflammation, bringing further risk for thrombotic events. Clinical and serological manifestations of antiphospholipid syndrome and systemic lupus erythematosus are very similar, so possible connection for these two autoimmune disorders is assumed. © 2014 Plavsic et al.
dc.identifier.urihttps://doi.org/10.3889/MJMS.1857-5773.2014.0437
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84908151549&doi=10.3889%2fMJMS.1857-5773.2014.0437&partnerID=40&md5=ddd84cbe616fa8022b88031c1b9aab37
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/8640
dc.subjectAnticoagulant therapy
dc.subjectAntiphospholipid antibodies
dc.subjectAntiphospholipid syndrome
dc.subjectSystemic lupus erythematosus
dc.subjectThrombosis
dc.titleSystemic lupus erythematosus and antiphospholipid syndrome
dspace.entity.typePublication

Files